Marked efficacy of a therapeutic strategy associating prednisone and plasma exchange followed by rituximab in two patients with refractory myopathy associated with antibodies to the signal recognition particle (SRP).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples